Pharm
Meclizine
search
Meclizine
, Antivert, Bonine, Medivert, Meclicot
See Also
Antihistamine
Anticholinergic Toxicity
Vertigo Management
Motion Sickness
Dimenhydrinate
Indications
Vertigo
Motion Sickness
Mechanism
See
Antihistamine
H1 Receptor
Antagonist
(
First Generation Antihistamine
)
Meclizine is a synthetic piperazine derivative with
Antihistamine
(moderate
Anticholinergic
) and
Antiemetic
activity
Precautions
Although FDA approved for children, FDA does not recommend routine
Antihistamine
use age <4 years
Deaths have occurred in younger children related to
Anticholinergic Toxicity
Dosing
Approved for age >=12 years
Vertigo
(not FDA approved)
Dose 25 mg orally four times daily as needed
Motion Sickness
Start: 25 to 50 mg orally 1 hour prior to travel
Next: 25 to 50 mg orally daily during travel
Adverse Effects
See
Antihistamine
See
Anticholinergic Toxicity
Sedation
Safety
Pregnancy category B
Unknown safety in
Lactation
Resources
Meclizine (DailyMed)
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=666dc4d8-7b16-4c3c-84e4-645548dbee68
References
Olson (2020) Clinical
Pharmacology
, Medmaster Miami, p. 146-7
Hamilton (2020) Tarascon Pocket Pharmacopoeia
Type your search phrase here